间充质干细胞治疗心肌缺血性疾病的临床研究进展

被引:7
作者
李娜 [1 ,2 ]
孔晴宇 [1 ,3 ]
辛毅 [1 ,2 ]
黄益民 [1 ,2 ]
张兆光 [1 ,3 ]
周玉杰 [1 ,4 ]
机构
[1] 首都医科大学附属北京安贞医院
[2] 北京市心肺血管疾病研究所细胞与分子生物学研究室
[3] 北京市心肺血管疾病研究所心外科
[4] 北京市心肺血管疾病研究所心内科
关键词
间充质干细胞,细胞治疗; 心肌梗死; 心肌缺血性疾病;
D O I
暂无
中图分类号
R542.22 [];
学科分类号
1002 ; 100201 ;
摘要
<正>心肌缺血性疾病导致梗死区心肌细胞不可逆死亡,疤痕组织形成,心室重构,心功能降低最终导致心力衰竭。尽管现行心脏内外科治疗可以很大程度地降低了急性心肌梗死的病死率。然而并不能使梗死区梗死心肌细胞再生,导致心功能不可逆的降低。间充质干细胞(mesenchymal stem cells,MSC)是来源于骨髓和脐带,可以在体外被培养扩增,具有分
引用
收藏
页码:377 / 379
页数:3
相关论文
共 9 条
[1]   骨髓间充质干细胞治疗缺血性心脏病的研究现状 [J].
孟庆涛 ;
王辉山 .
心肺血管病杂志, 2010, 29 (05) :430-432
[2]   小鼠活体内hMSCs干细胞生物发光示踪监测 [J].
黄益民 ;
张颖 ;
辛毅 ;
胡著涛 ;
罗毅 .
心肺血管病杂志, 2010, 29 (04) :322-328
[3]  
Assessment of left ventricular segmental function after autologous bone marrow stem cells transplantation in patients with acute myocardial infarction by tissue tracking and strain imaging[J]. RUAN Wen, PAN Cui-zhen, HUANG Guo-qian, LI Yan-lin, GE Jun-bo and SHU Xian-hong Department of Cardiology, Zhongshan Hospital of Fudan University, Shanghai 200032, China. Chinese Medical Journal. 2005(14)
[4]   Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors [J].
Ieda, Masaki ;
Fu, Ji-Dong ;
Delgado-Olguin, Paul ;
Vedantham, Vasanth ;
Hayashi, Yohei ;
Bruneau, Benoit G. ;
Srivastava, Deepak .
CELL, 2010, 142 (03) :375-386
[5]  
A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction[J] . Joshua M. Hare,Jay H. Traverse,Timothy D. Henry,Nabil Dib,Robert K. Strumpf,Steven P. Schulman,Gary Gerstenblith,Anthony N. DeMaria,Ali E. Denktas,Roger S. Gammon,James B. Hermiller,Mark A. Reisman,Gary L. Schaer,Warren Sherman. Journal of the American College of Cardiology . 2009 (24)
[6]  
Cardiomyogenic differentiation of human bone marrow mesenchymal cells: Role of cardiac extract from neonatal rat cardiomyocytes[J] . V. Labovsky,E.L. Hofer,L. Feldman,V. Fernández Vallone,H. García Rivello,A. Bayes-Genis,A. Hernando Insúa,M.J. Levin,N.A. Chasseing. Differentiation . 2009 (2)
[7]  
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J] . M Dominici,K Le Blanc,I Mueller,I Slaper-Cortenbach,Fc Marini,Ds Krause,Rj Deans,A Keating,Dj Prockop,Em Horwitz. Cytotherapy . 2006 (4)
[8]  
Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium[J] . Demosthenes G.Katritsis,Panagiota A.Sotiropoulou,EvangeliaKarvouni,IliasKarabinos,SocratesKorovesis,Sonia A.Perez,Eutychios M.Voridis,MichaelPapamichail. Cathet. Cardiovasc. Intervent. . 2005 (3)
[9]   Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction [J].
Chen, SL ;
Fang, W ;
Ye, F ;
Liu, YH ;
Qian, J ;
Shan, S ;
Zhang, J ;
Zhao, RCH ;
Liao, LM ;
Lin, S ;
Sun, JP .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (01) :92-95